Recombinant Human CST5 Protein，His

CST5 (Cystatin M/E) is a member of the cystatin superfamily that plays a crucial role in regulating protease activity in various biological processes, including immune response, tissue remodeling, and cancer progression. Disruption of CST5 function has been implicated in several pathological conditions, making it a target of interest in biomedical research. The protein exhibits inhibitory effects on cathepsins, which are cysteine proteases involved in protein degradation and cellular signaling pathways. Recent studies have highlighted its potential as a biomarker for certain cancers and as a therapeutic target for modulating tumor microenvironments. The recombinant production of CST5 has enabled detailed studies of its structure-function relationships, leading to insights into its mechanistic roles in disease. Additionally, CST5's unique ability to influence cell behavior and promote apoptosis in malignant cells suggests its promise in developing new cancer therapies. As researchers continue to explore CST5's diverse functions and interactions, the understanding of its role in health and disease expands, paving the way for innovative approaches to targeting this protein in clinical settings. The ongoing investigation into CST5 and its recombinant form aims to unravel the complexities of cystatin family proteins and their potential applications in medicine.